Whether Merck is playing hardball by foot dragging BCG increased production is up for debate. These companies do all types of things to time releases, trials, etc, their way. What we know is that Merck is trialing Keytruda with DCVax-l and poly-iclc.
Market Data 
Markets 
AI
